Guidelines of clinical trial during COVID-19

15th July, the center for drug evaluation of NMPA issued Guidelines of clinical trial during COVID-19, which will be implemented from the date of promulgation. The guiding principles include: Subject protectionPharmacovigilance and risk managementTimely reporting and risk assessment of drug clinical trial informationDesign and implementation of clinical trialClinical trial safety management Writing of clinical trial report

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is CNY 10,000 Best! Paolo yue Email: Cell: 008613501397114

Existing Users Log In
New User Registration
*Required field